{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:41:59Z","timestamp":1792078919445,"version":"4.4.0"},"reference-count":40,"publisher":"American Medical Association (AMA)","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2019,6,18]]},"DOI":"10.1001\/jama.2019.7437","type":"journal-article","created":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T11:00:50Z","timestamp":1560855650000},"page":"2316","source":"Crossref","is-referenced-by-count":319,"title":["Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia"],"prefix":"10.1001","volume":"321","author":[{"suffix":"Jr","given":"Clifford R.","family":"Jack","sequence":"first","affiliation":[{"name":"Department of Radiology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather J.","family":"Wiste","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry M.","family":"Therneau","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Weigand","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Knopman","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M.","family":"Mielke","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val J.","family":"Lowe","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashanthi","family":"Vemuri","sequence":"additional","affiliation":[{"name":"Department of Radiology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary M.","family":"Machulda","sequence":"additional","affiliation":[{"name":"Department of Psychiatry & Psychology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher G.","family":"Schwarz","sequence":"additional","affiliation":[{"name":"Department of Radiology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Gunter","sequence":"additional","affiliation":[{"name":"Department of Radiology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L.","family":"Senjem","sequence":"additional","affiliation":[{"name":"Department of Radiology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Graff-Radford","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Radiology, Mayo Clinic, Rochester, Minnesota"},{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosebud O.","family":"Roberts","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter A.","family":"Rocca","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Petersen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"joi190054r1","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease.","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"1","key":"joi190054r2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease.","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement"},{"issue":"3","key":"joi190054r3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jalz.2016.08.005","article-title":"Defining imaging biomarker cut points for brain aging and Alzheimer\u2019s disease.","volume":"13","author":"Jack","year":"2017","journal-title":"Alzheimers Dement"},{"issue":"3","key":"joi190054r4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1056\/NEJMoa0809437","article-title":"Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect.","volume":"361","author":"Caselli","year":"2009","journal-title":"N Engl J Med"},{"issue":"1","key":"joi190054r5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000115751","article-title":"The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics.","volume":"30","author":"Roberts","year":"2008","journal-title":"Neuroepidemiology"},{"issue":"2","key":"joi190054r6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.mayocp.2011.11.009","article-title":"Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project.","volume":"87","author":"St Sauver","year":"2012","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"joi190054r7","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/jim.2004.256.issue-3","article-title":"Mild cognitive impairment as a diagnostic entity.","volume":"256","author":"Petersen","year":"2004","journal-title":"J Intern Med"},{"issue":"10","key":"joi190054r9","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/j.mayocp.2014.07.010","article-title":"Prevalence of multimorbidity in a geographically defined American population: patterns by age, sex, and race\/ethnicity.","volume":"89","author":"Rocca","year":"2014","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"joi190054r10","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S1474-4422(17)30077-7","article-title":"Age-specific and sex-specific prevalence of cerebral \u00df-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study.","volume":"16","author":"Jack","year":"2017","journal-title":"Lancet Neurol"},{"issue":"3","key":"joi190054r11","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh Compound-B.","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann Neurol"},{"issue":"2","key":"joi190054r12","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3233\/JAD-122059","article-title":"Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807.","volume":"34","author":"Chien","year":"2013","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"joi190054r13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","article-title":"The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET.","volume":"11","author":"Klunk","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"19","key":"joi190054r14","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1212\/WNL.0000000000002100","article-title":"Spectrum of cognition short of dementia: Framingham Heart Study and Mayo Clinic Study of Aging.","volume":"85","author":"Knopman","year":"2015","journal-title":"Neurology"},{"issue":"20","key":"joi190054r15","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1212\/WNL.0000000000004652","article-title":"Weighting and standardization of frequencies to determine prevalence of AD imaging biomarkers.","volume":"89","author":"Roberts","year":"2017","journal-title":"Neurology"},{"issue":"8","key":"joi190054r16","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1080\/13854046.2013.836567","article-title":"Practice effects and longitudinal cognitive change in normal aging vs incident mild cognitive impairment and dementia in the Mayo Clinic Study of Aging.","volume":"27","author":"Machulda","year":"2013","journal-title":"Clin Neuropsychol"},{"issue":"1","key":"joi190054r17","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ana.24546","article-title":"Tau positron emission tomographic imaging in aging and early Alzheimer disease.","volume":"79","author":"Johnson","year":"2016","journal-title":"Ann Neurol"},{"issue":"3","key":"joi190054r18","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1523\/JNEUROSCI.2028-17.2017","article-title":"Entorhinal tau pathology, episodic memory decline, and neurodegeneration in aging.","volume":"38","author":"Maass","year":"2018","journal-title":"J Neurosci"},{"issue":"4","key":"joi190054r19","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/00004728-199007000-00011","article-title":"Correction of PET data for partial volume effects in human cerebral cortex by MR imaging.","volume":"14","author":"Meltzer","year":"1990","journal-title":"J Comput Assist Tomogr"},{"issue":"228","key":"joi190054r20","doi-asserted-by":"publisher","first-page":"228fs13","DOI":"10.1126\/scitranslmed.3007941","article-title":"The A4 study: stopping AD before symptoms begin?","volume":"6","author":"Sperling","year":"2014","journal-title":"Sci Transl Med"},{"issue":"7618","key":"joi190054r21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u00df plaques in Alzheimer\u2019s disease.","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"issue":"11","key":"joi190054r23","doi-asserted-by":"publisher","first-page":"e940","DOI":"10.1212\/WNL.0000000000005124","article-title":"Tau-negative amnestic dementia masquerading as Alzheimer disease dementia.","volume":"90","author":"Botha","year":"2018","journal-title":"Neurology"},{"key":"joi190054r24","first-page":"awz099","article-title":"Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report.","author":"Nelson","year":"2019","journal-title":"Brain"},{"issue":"5","key":"joi190054r25","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.","volume":"71","author":"Nelson","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"joi190054r26","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers.","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol"},{"issue":"1","key":"joi190054r27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/ana.v84.1","article-title":"Combined neuropathological pathways account for age-related risk of dementia.","volume":"84","author":"Power","year":"2018","journal-title":"Ann Neurol"},{"issue":"5","key":"joi190054r28","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00401-011-0826-y","article-title":"Alzheimer\u2019s disease is not \u201cbrain aging\u201d: neuropathological, genetic, and epidemiological human studies.","volume":"121","author":"Nelson","year":"2011","journal-title":"Acta Neuropathol"},{"issue":"24","key":"joi190054r29","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","article-title":"Mixed brain pathologies account for most dementia cases in community-dwelling older persons.","volume":"69","author":"Schneider","year":"2007","journal-title":"Neurology"},{"issue":"6","key":"joi190054r30","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1212\/WNL.0000000000001831","article-title":"Multiple pathologies are common and related to dementia in the oldest-old: the 90+ Study.","volume":"85","author":"Kawas","year":"2015","journal-title":"Neurology"},{"issue":"1","key":"joi190054r31","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/brain\/awx320","article-title":"Widespread brain tau and its association with ageing, Braak stage and Alzheimer\u2019s dementia.","volume":"141","author":"Lowe","year":"2018","journal-title":"Brain"},{"key":"joi190054r32","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.neuroimage.2017.05.058","article-title":"Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer\u2019s disease.","volume":"157","author":"Maass","year":"2017","journal-title":"Neuroimage"},{"issue":"2","key":"joi190054r33","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/ana.v80.2","article-title":"In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum.","volume":"80","author":"Cho","year":"2016","journal-title":"Ann Neurol"},{"issue":"3","key":"joi190054r34","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1474-4422(18)30028-0","article-title":"Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer\u2019s disease: a longitudinal study.","volume":"17","author":"Gordon","year":"2018","journal-title":"Lancet Neurol"},{"issue":"13","key":"joi190054r35","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1001\/jama.2019.2000","article-title":"Association of amyloid positron emission tomography with subsequent change in clinical management among Medicare beneficiaries with mild cognitive impairment or dementia.","volume":"321","author":"Rabinovici","year":"2019","journal-title":"JAMA"},{"issue":"10","key":"joi190054r36","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/S1474-4422(16)30125-9","article-title":"Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer\u2019s disease pathophysiology (SNAP) or Alzheimer\u2019s disease pathology: a longitudinal study.","volume":"15","author":"Burnham","year":"2016","journal-title":"Lancet Neurol"},{"issue":"4","key":"joi190054r37","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid \u00df deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study.","volume":"12","author":"Villemagne","year":"2013","journal-title":"Lancet Neurol"},{"issue":"1","key":"joi190054r38","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jalz.2013.01.004","article-title":"The neuropsychology of normal aging and preclinical Alzheimer\u2019s disease.","volume":"10","author":"Caselli","year":"2014","journal-title":"Alzheimers Dement"},{"issue":"pt 1","key":"joi190054r39","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/brain\/awt286","article-title":"Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer\u2019s disease.","volume":"137","author":"Lim","year":"2014","journal-title":"Brain"},{"issue":"9","key":"joi190054r40","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.jalz.2017.01.018","article-title":"Early and late change on the preclinical Alzheimer\u2019s cognitive composite in clinically normal older individuals with elevated amyloid \u00df.","volume":"13","author":"Mormino","year":"2017","journal-title":"Alzheimers Dement"},{"key":"joi190054r8","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994","edition":"4th ed"},{"key":"joi190054r22","first-page":"7060","volume-title":"Early Alzheimer's Disease: Developing Drugs for Treatment: Guidance for Industry","author":"Food and Drug Administration","year":"2018"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jama\/article-pdf\/321\/23\/2316\/17668701\/jama_jack_2019_oi_190054.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T11:00:51Z","timestamp":1560855651000},"score":1,"resource":{"primary":{"URL":"http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.2019.7437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,18]]},"references-count":40,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2019,6,18]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2019.7437","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6,18]]}}}